gms | German Medical Science

27. Jahrestagung der Deutschsprachigen Arbeitsgemeinschaft für Verbrennungsbehandlung (DAV 2009)

14.01. bis 17.01.2009, Leogang, Österreich

The Use of Biosynthetic Skin Substitute (Biobrane) in the Treatment of Exfoliative Skin Disorders

Meeting Abstract

Search Medline for

  • D. Tobbia - Division of Plastic Surgery, University of Toronto, Toronto, Ontario, Kanada
  • T. Sattler - Division of Plastic Surgery, University of Toronto, Toronto, Ontario, Kanada

DAV 2009. 27. Jahrestagung der deutschsprachigen Arbeitsgemeinschaft für Verbrennungsbehandlung. Leogang, Österreich, 14.-17.01.2009. Düsseldorf: German Medical Science GMS Publishing House; 2009. Doc09dav82

doi: 10.3205/09dav82, urn:nbn:de:0183-09dav820

Published: March 19, 2009

© 2009 Tobbia et al.
This is an Open Access article distributed under the terms of the Creative Commons Attribution License ( You are free: to Share – to copy, distribute and transmit the work, provided the original author and source are credited.



Toxic epidermal necrolysis (TEN) is a rare dermatologic disease that is part of a spectrum of drug related exfoliative disorders including Steven-Johnson syndrome (SJS) and SJS/TEN overlap. These are characterized by a variable degree of epidermal detachment at the dermoepidermal junction, resulting in microscopic changes comparable with those that occur in superficial dermal burns, justifying the need for patient management in a specialized burn unit. The main objective of this study was to determine the time required for the wounds to heal and the infection rates when using Biobrane for skin coverage.

A retrospective chart review of drug related exfoliative disorders from January 1999 to December 2007 was performed. The parameters included in the study were patient demographics, time from disease onset to burn unit admission, total surface area of detached skin and/or mucosal involvement, the area and anatomy covered with Biobrane, healing time, complications, mortality and outcome.

A total of thirty-two patients were identified with either TEN or SJS/TEN overlap. The patients studied had a mean age of 55.7 ± 21.1 years (range, 18 to 86 years). Time from initial onset of symptoms to burn unit admission was 7.2 ± 3.36 days (range, 3 to 18 days), body surface area of epidermal detachment was 41% ± 23% (range, 10% to 100%). Twenty-eight patients (87.5%) required wound coverage with Biobrane, the mean surface area covered was 39.2% ± 20.9% (range, 10% to 90%), time from admission to complete reepithelialization in the surviving patients was 10 ± 3.9 days (range 5 to 20 days). Only 4 patients (14.3%) developed a wound infection, two of those required removal of Biobrane.

Skin coverage with a synthetic skin substitute such as Biobrane early in the course of treatment provides barrier protection, helping to reduce wound infection rates and promote rapid healing.